Jane Street’s Jupiter Neurosciences JUNS Stock Holding History

Jane Street’s Portfolio JUNS Stock Details JUNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-14,457	Closed	-$14.7K	–	13359
2025 Q4	$14.7K	Buy	14,457 +2,065	+17%	+$2.75K	﹤0.01%	10779
2025 Q3	$21.8K	Buy	+12,392	New	+$18.8K	﹤0.01%	10518

Other funds holding JUNS

Vestor Capital Chicago, Illinois $1.38B AUM 39.2% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

YAG

Yorkville Advisors Global Mountainside, New Jersey $155M AUM 58.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MidFirst Bank Oklahoma City, Oklahoma $1.21B AUM

Jane Street's JUNS Position: Q1 2026 in Review

Jane Street sold out of Jupiter Neurosciences (JUNS) in Q1 2026, closing a stake of 14,457 shares — an estimated $14.7K sold.

Jane Street first reported a position in JUNS in Q3 2025 and held it in 2 quarters. The position peaked at $21.8K in Q3 2025. 10 funds tracked by Wall St. Rank hold JUNS as of Q1 2026.

Jane Street reported no remaining Jupiter Neurosciences position as of Q1 2026 after selling out during the quarter.
Jane Street sold 14,457 Jupiter Neurosciences shares in Q1 2026, an estimated $14.7K.
Jane Street first reported a position in Jupiter Neurosciences in Q3 2025 and held it in 2 quarters.
Jane Street's Jupiter Neurosciences position peaked at $21.8K in Q3 2025.
10 funds tracked by Wall St. Rank held Jupiter Neurosciences as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.